Mayo Clinic, Current partner on AI-based COVID-19 monitoring
The healthcare institution and life-sciences technology platform are working together to use artificial intelligence to detect and understand the virus.
The healthcare institution and life-sciences technology platform are working together to use artificial intelligence to detect and understand the virus.
The federal agency continues to offer advice and take actions related to COVID-19, impacting drug development, clinical trials and other activities.
The decentralized trial technology is intended to enable sites and sponsors to continue trials in the face of COVID-19 and other disruptive events.
The company is putting artificial intelligence to work in the hopes of coming up with more precise, effective tests and therapies for a range of diseases.